Published in Arch Biochem Biophys on September 29, 2007
Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme. J Mol Biol (2009) 1.17
Structure, function, and regulation of insulin-degrading enzyme. Vitam Horm (2009) 0.86
Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues. Int J Mol Med (2008) 0.85
Modulation of insulin degrading enzyme activity and liver cell proliferation. Cell Cycle (2015) 0.85
Structural changes in intermediate filament networks alter the activity of insulin-degrading enzyme. FASEB J (2009) 0.83
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis. Eur J Med Chem (2014) 0.82
Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines. Biol Chem (2008) 0.76
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med (2015) 3.67
Food frequency questionnaire results correlate with metabolic control in insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. J Am Diet Assoc (2004) 1.42
Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab (2003) 1.36
Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Am J Med Sci (2004) 1.30
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures. Diabetes (2003) 1.21
Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care (2003) 1.20
Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr (2008) 1.12
Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care (2010) 1.05
A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES). Arch Intern Med (2004) 1.03
Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. BMC Health Serv Res (2006) 1.03
Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity (Silver Spring) (2008) 1.00
Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance. Arterioscler Thromb Vasc Biol (2008) 0.97
Gamma-synuclein is an adipocyte-neuron gene coordinately expressed with leptin and increased in human obesity. J Nutr (2008) 0.97
Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Clin Endocrinol (Oxf) (2004) 0.95
Polymorphisms in the oxygen-regulated protein 150 gene (ORP150) are associated with insulin resistance in Pima Indians. Diabetes (2002) 0.92
Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians. Hypertension (2004) 0.91
Inhibition of proteasome activity by selected amino acids. Metabolism (2003) 0.90
Identification of novel putative membrane proteins selectively expressed during adipose conversion of 3T3-L1 cells. Biochem Biophys Res Commun (2002) 0.90
Insulin metabolism in human adipocytes from subcutaneous and visceral depots. Biochem Biophys Res Commun (2010) 0.90
Differential expression of matrix metalloproteinase 3 (MMP3) in preadipocytes/stromal vascular cells from nonobese nondiabetic versus obese nondiabetic Pima Indians. Diabetes (2006) 0.89
The role of insulin receptor substrate-1 gene (IRS1) in type 2 diabetes in Pima Indians. Diabetes (2003) 0.88
Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes. J Diabetes Complications (2005) 0.88
Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages. Am J Physiol Endocrinol Metab (2009) 0.84
Beneficial effects of a glyburide/metformin combination preparation in type 2 diabetes mellitus. Am J Med Sci (2003) 0.84
Basic fibroblast growth factor predicts cardiovascular disease occurrence in participants from the veterans affairs diabetes trial. Front Endocrinol (Lausanne) (2013) 0.83
Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes (2003) 0.83
Observation on renal outcomes in the Veterans Affairs Diabetes Trial. Diabetes Care (2011) 0.83
11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue and prospective changes in body weight and insulin resistance. Obesity (Silver Spring) (2006) 0.83
Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial). Am J Cardiol (2006) 0.83
Overweight and obesity in postpartum Hispanic women. Health Care Women Int (2008) 0.82
Evaluation of the microsomal glutathione S-transferase 3 (MGST3) locus on 1q23 as a Type 2 diabetes susceptibility gene in Pima Indians. Hum Genet (2003) 0.81
Reliability and validity of the DCP among hispanic veterans. Eval Health Prof (2005) 0.81
Blood glucose monitoring is associated with better glycemic control in type 2 diabetes: a database study. J Gen Intern Med (2008) 0.81
Control of proteolysis: hormones, nutrients, and the changing role of the proteasome. Curr Opin Clin Nutr Metab Care (2004) 0.80
Factors affecting hypoglycemia awareness in insulin-treated type 2 diabetes: The Diabetes Outcomes in Veterans Study (DOVES). Diabetes Res Clin Pract (2004) 0.80
Hypoglycemia in type 2 diabetes: a critical review. Biomed Pharmacother (2004) 0.80
Retinoblastoma protein co-purifies with proteasomal insulin-degrading enzyme: implications for cell proliferation control. Biochem Biophys Res Commun (2010) 0.79
UCP5/BMCP1 transcript isoforms in human skeletal muscle: relationship of the short-insert isoform with lipid oxidation and resting metabolic rates. Mol Genet Metab (2002) 0.77
Risk factor management in stable, insulin-treated patients with Type 2 diabetes: the Diabetes Outcomes in Veterans Study. J Diabetes Complications (2003) 0.77
Polymorphisms in the gene encoding 11B-hydroxysteroid dehydrogenase type 1 (HSD11B1) and lifetime cognitive change. Neurosci Lett (2005) 0.76
Evaluating once- and twice-daily self-monitored blood glucose testing strategies for stable insulin-treated patients with type 2 diabetes : the diabetes outcomes in veterans study. Diabetes Care (2002) 0.76
Reduced action of insulin glargine on protein and lipid metabolism: possible relationship to cellular hormone metabolism. Metabolism (2004) 0.76
Insulin glulisine: viewpoints. Drugs (2006) 0.75
Undoing Flexner: the beginning of the end of academic medicine in America. Am J Med Sci (2011) 0.75
Pancreas transplantation for type I diabetes mellitus. Postgrad Med (1994) 0.75
Adoption of a new technology in a Veterans Affairs national formulary system with local implementation: the insulin glargine example. Manag Care Interface (2007) 0.75